Clinical trial
Effectiveness of Influenza Vaccination Among General Practitioners
NCT00221676 · University Hospital, Antwerp, Other · Completed
Key facts
| NCT number | NCT00221676 |
|---|---|
| Title | Effectiveness of Influenza Vaccination Among General Practitioners |
| Official title | Effectiveness of Influenza Vaccination (Alfarix)in Preventing Clinical Influenza Cases Among General Practitioners: Non-Randomized Clinical Trial. |
| Lead sponsor | University Hospital, Antwerp, Other |
| Collaborators | Universiteit Antwerpen Eurogenerics NV Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Alfarix |
| Enrollment | 300 |
| Start date | Jul 1, 2002 |
| Completion | Jun 1, 2004 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 28, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: